Top

Published in:

01-07-2019 | Original Article

Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort

Authors: T. Bach, I. Giannakis, A. Bachmann, C. Fiori, Fernando Gomez-Sancha, T. R. W. Herrmann, C. Netsch, M. Rieken, C. M. Scoffone, L. Tunc, J. J. Rassweiler, E. Liatsikos

Published in: World Journal of Urology | Issue 7/2019

Abstract

Purpose

Aquablation of the prostate using the AquaBeam™ system promises equivalent functional outcomes, reduced learning curve, and improved sexual function compared to transurethral prostate resection as shown in prospective randomized trials. This prospective cohort study aims to evaluate if published results can be transferred into the clinical routine in a non-selected patient collective.

Methods

This study includes all patients treated between September 2017 and June 2018 with Aquablation of the prostate. Patients have been evaluated prospectively for the perioperative course and early follow-up. Besides voiding parameter and symptom score, TRUS-volume change, ejaculatory function, and adverse events have been recorded.

Results

118 consecutive patients have been treated in the given time. Aquablation could be carried out successfully in all patients. IPSS, QoL, Qmax, and PVR improved significantly after the procedure and continued to improve during 3-month follow-up. Mean OR time was 20 min, TRUS volume decreased by 65%, and 73% of the patients retained antegrade ejaculation. Thirteen adverse events (> Clavien-Dindo I) occurred in 10 patients.

Conclusion

The surgical ablation of the prostate using Aquablation achieved significant and immediate improvement of functional voiding parameters Qmax and PVR as well as symptomatic improvement of IPSS and QoL. Aquablation seems to be safe and effective with a low perioperative complication profile even in a non-selected group of patients.

Herrmann TR, Georgiou A, Bach T, Gross AJ, Oelke M (2009) Laser treatments of the prostate vs TURP/open prostatectomy: systematic review of urodynamic data. Minerva Urol Nefrol 61(3):309–324PubMed

Cornu JN (2016) Bipolar, monopolar, photovaporization of the prostate, or holmium laser enucleation of the prostate: how to choose what’s best? Urol Clin North Am 43(3):377–384. https://doi.org/10.1016/j.ucl.2016.04.006 CrossRefPubMed

Herrmann TR (2016) Enucleation is enucleation is enucleation is enucleation. World J Urol 34(10):1353–1355. https://doi.org/10.1007/s00345-016-1922-3 (Epub 2016 Sep 1) CrossRefPubMed

Herrmann TR (2016) Long-term outcome after endoscopic enucleation of the prostate: from monopolar enucleation to HoLEP and from HoLEP to EEP. Urologe A. 55(11):1446–1454CrossRefPubMed

Trueman P, Hood SC, Nayak US, Mrazek MF (1999) Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK. BJU Int. 83(4):410–415CrossRefPubMed

Lim KB (2017) Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 4(3):148–151. https://doi.org/10.1016/j.ajur.2017.06.004 (Epub 2017 Jun 9) CrossRefPubMedPubMedCentral

Lin Y, Wu X, Xu A, Herrmann TR et al (2016) Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. World J Urol 34(9):1207–1219. https://doi.org/10.1007/s00345-015-1735-9 (Epub 2015 Dec 23) CrossRefPubMed

Rau HG, Duessel AP, Wurzbacher S (2008) The use of water-jet dissection in open and laparoscopic liver resection. HPB (Oxford). 10(4):275–280. https://doi.org/10.1080/13651820802167706 CrossRefPubMedPubMedCentral

Basting RF, Djakovic N, Widmann P (2000) Use of water jet resection in organ-sparing kidney surgery. J Endourol 14(6):501–505CrossRefPubMed

10.

Honl M, Rentzsch R, Lampe F et al (2000) Water-jet cutting of bone and bone cement. A study of the possibilities and limitations of a new technique. Biomed Tech 45:222–227CrossRef

11.

Ortel J, Gaab MR, Piek J (2003) Water jet resection of brain metastases—first clinical results with 10 patients. Eur J Surg Oncol. 29(4):407–414CrossRef

12.

Fritsche HM, Otto W, Eder F et al (2011) Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol 25(10):1599–1603. https://doi.org/10.1089/end.2011.0042 (Epub 2011 Aug 4) CrossRefPubMed

13.

Nagele U, Kugler M, Herrmann TR et al (2011) Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection. World J Urol 29(4):423–427. https://doi.org/10.1007/s00345-011-0653-8 (Epub 2011 Feb 9) CrossRefPubMed

14.

Faber K (2015) Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia. J Endourol 29:63–69. https://doi.org/10.1089/end.2014.0304 CrossRefPubMed

15.

Gilling P, Reuther R, Kahokehr A, Fraundorfer M (2016) Aquablation—image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int. 117(6):923–929. https://doi.org/10.1111/bju.13358 (Epub 2015 Nov 19) CrossRefPubMed

16.

Gilling P, Anderson P, Tan A (2017) Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol 197(6):1565–1572. https://doi.org/10.1016/j.juro.2017.01.056 (Epub 2017 Jan 20) CrossRefPubMed

17.

Gilling P, Barber N, Bidair M et al (2018) Water: a double-blind, randomized, controlled trial of aquablation^® vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199(5):1252–1261. https://doi.org/10.1016/j.juro.2017.12.065 (Epub 2018 Jan 31) CrossRefPubMed

18.

Cornu JN, Ahyai S, Bachmann A et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017 (Epub 2014 Jun 25) CrossRefPubMed

19.

Desai M, Bidair M et al (2018) Water II (80–150 mL) procedural outcomes. BJU Int. https://doi.org/10.1111/bju.14360 (Epub ahead of print) CrossRefPubMed

20.

Desai M, Singh A et al (2018) Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients. BJU Int. 121(6):945–951. https://doi.org/10.1111/bju.14126 (Epub 2018 Feb 4) CrossRefPubMed

21.

Green JS, Bose P et al (1996) How complete is a transurethral resection of the prostate? Br J Urol 77(3):398–400CrossRefPubMed

22.

Wilson LC, Gilling PJ (2006) A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 g: results at 2 years. Eur Urol 50(3):569–573 (Epub 2006 May 2) CrossRefPubMed

23.

Gilling P (2014) First-in-human clinical experience of a novel treatment for BPH: image guided robotically-assisted waterjet ablation of the prostate. J Endourol 28(Supplement):1

24.

Plante M, Gilling P (2018) Symptom relief and anejaculation after aquablation or TURP: subgroup analysis from a blinded randomized trial. BJU Int. https://doi.org/10.1111/bju.14426 (Epub ahead of print) CrossRefPubMed

25.

Gilling P, Anderson P et al (2017) Aquablation of the Prostate for symptomatic benign prostatic hyperplasia: 1-year results. J Urol 197:1565–1572CrossRefPubMed

26.

Kasivisvanathan V et al (2018) Aquablation versus transurethral resection of the prostate: 1 year United States—cohort outcomes. Can J Urol. 25(3):9317–9322PubMed

Title: Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort
Authors: T. Bach
I. Giannakis
A. Bachmann
C. Fiori
Fernando Gomez-Sancha
T. R. W. Herrmann
C. Netsch
M. Rieken
C. M. Scoffone
L. Tunc
J. J. Rassweiler
E. Liatsikos
Publication date: 01-07-2019
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 7/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2509-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2019

Photoselective vaporization has comparative efficacy and safety among high-risk benign prostate hyperplasia patients on or off systematic anticoagulation: a meta-analysis

PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?

Does mechanical morcellation of large glands compromise incidental prostate cancer detection on specimen analysis? A pathological comparison with open simple prostatectomy

The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis

Role of MRI in planning radical prostatectomy: what is the added value?